PT - JOURNAL ARTICLE AU - Jin, Heejin AU - Lee, Jeewon AU - Oh, Sohee AU - Lee, Sanghun AU - Won, Sungho TI - Major depressive disorder but not bipolar disorder and schizophrenia is a causal factor for type 2 diabetes as determined by Mendelian randomization AID - 10.1101/2020.09.12.20193060 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.12.20193060 4099 - http://medrxiv.org/content/early/2020/09/13/2020.09.12.20193060.short 4100 - http://medrxiv.org/content/early/2020/09/13/2020.09.12.20193060.full AB - Objective In many epidemiologic studies, type 2 diabetes has been reported to be associated with severe mental illness (SMI) such as schizophrenia (SCZ), bipolar disorder (BPD), and major depressive disorder (MDD). However, the relationship between SMI and type 2 diabetes is bi-directional, and the causal relationship remains unclear due to various confounders. Therefore, a Mendelian randomization (MR) study is necessary to identify the causality between them.Research Design and Methods We conducted a two-sample MR study to identify the causal effect of SMI on type 2 diabetes using the inverse-variance weighted (IVW), MR-Egger, MR-Egger with a simulation extrapolation, weighted median approach, and MR-Pleiotropy RESidual Sum and Outlier methods. The most appropriate method was selected according to the instrument variables assumption.Results We found that MDD had a significant causal effect on type 2 diabetes from the results obtained using the IVW method (Odds ratio (OR): 1.191, 95% CI: 1.036–1.372, P = 0.014); however, this was not observed for BPD (IVW, OR: 1.006, 95% CI: 0.918–1.104, P = 0.892) or SCZ (IVW, OR: 1.016, 95% CI: 0.974–1.059, P = 0.463). The absence of reverse-causality between MDD and type 2 diabetes was also demonstrated from bi-directional MR studies.Conclusions These results clearly reveal important knowledge on the causal role of MDD in the risk of type 2 diabetes without a residual confounding, whereas the causality of BPD and SCZ was not shown. Therefore, careful attention should be paid to MDD patients in type 2 diabetes prevention and treatment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Industrial Core Technology Development Program (20000134) funded by the Ministry of Trade, Industry and Energy (MOTIE, Korea), and the National Research Foundation of Korea (2017M3A9F3046543).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not AvailableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data can be downloaded from the following link. https://www.med.unc.edu/pgc/download-results/ http://diagram-consortium.org/downloads.html